Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Capital Expenditure Over TimeContracting
Percentile Rank38
Studio
Year-over-Year Change

Cash spent on acquiring or upgrading physical assets

Latest
$-158000.00
↑ 19% vs avg
Percentile
P38
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-195000.00
Historical baseline
PeriodValueYoY Change
TTM$-158000.00-259.1%
2024$-44000.00+70.5%
2023$-149000.00+75.7%
2022$-612000.00-220.4%
2021$-191000.00+58.6%
2020$-461000.00-229.3%
2019$-140000.00-
2018$0.00-
2017$0.00-